banter and General Discussion, page-6739

These threads are reminiscent of the threads immediately before the previous attempt at FDA approval, or before the results of the Covid trial, the CLBP trial, the CHF trial, etc.

Counting chickens.

It's nice to daydream. But be realistic.

First step is getting approval - fingers crossed they do.

The price will obviously pop - but who thinks it will actually pop back to $5? That's a massive increase.

But who here would sell then? I'm guessing none of the usual suspects - they're waiting for that sweet $50, right?

After it pops on excitement, it'll retrace. And then the reality will kick in - slow growth of sales, increased expenditure for sales, marketing, further trials. More cap raises, etc.

Even if MSB gets approval, that's just the start of the journey towards a self sustaining company, and in the medical field it's a long journey. Don't forget, this is already nearly a billion dollar company - there's already a lot of hype baked in.